BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9816201)

  • 1. Tissue and tumor distribution of C-penclomedine in rats.
    O'Reilly S; Hartman NR; Grossman SA; Strong JM; Struck RF; Eller S; Lesser GJ; Donehower RC; Rowinsky EK
    Clin Cancer Res; 1996 Mar; 2(3):541-8. PubMed ID: 9816201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine and human in vivo penclomedine metabolism.
    Hartman NR; O'Reilly S; Rowinsky EK; Collins JM; Strong JM
    Clin Cancer Res; 1996 Jun; 2(6):953-62. PubMed ID: 9816256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Res; 1991 Apr; 51(8):1979-83. PubMed ID: 2009516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro metabolism of penclomedine in mouse, rat, and human systems.
    Hartman NR; Leo KU; Brewer TG; Strong JM
    Drug Metab Dispos; 1998 Jun; 26(6):513-9. PubMed ID: 9616185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.
    Plowman J; Harrison SD; Dykes DJ; Paull KD; Narayanan VL; Tobol HK; Martin J; Griswold DP
    Cancer Res; 1989 Apr; 49(8):1909-15. PubMed ID: 2702634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720].
    Reid JM; Mathiesen DA; Benson LM; Kuffel MJ; Ames MM
    Cancer Res; 1992 May; 52(10):2830-4. PubMed ID: 1581896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy.
    Liu G; Berlin J; Tutsch KD; Van Ummersen L; Dresen A; Marnocha R; Arzomanian R; Alberti D; Feierabend C; Binger K; Wilding G
    Clin Cancer Res; 2002 Mar; 8(3):706-11. PubMed ID: 11895899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor.
    Yamaya H; Saeki M; Yoshida K; Shibata J; Yano S; Sato Y; Takao A; Shindo T; Buzdar AU; Nagayama S
    Drug Metab Dispos; 2006 Feb; 34(2):331-8. PubMed ID: 16299166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine.
    Waud WR; Tiwari A; Schmid SM; Shih TW; Strong JM; Hartman NR; O'Reilly S; Struck RF
    Cancer Res; 1997 Mar; 57(5):815-7. PubMed ID: 9041177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats.
    Myers SR; Spinnato JA
    Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
    Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
    Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine.
    O'Reilly S; Hartman NR; Bowling KM; Rowinsky EK; Donehower RC; Collins J; Strong JM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):223-8. PubMed ID: 11592344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14 C-bortezomib.
    Hemeryck A; Geerts R; Monbaliu J; Hassler S; Verhaeghe T; Diels L; Verluyten W; van Beijsterveldt L; Mamidi RN; Janssen C; De Coster R
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):777-87. PubMed ID: 17285316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution of 14C-diazepam and its metabolites in rats.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    Drug Metab Dispos; 1982; 10(6):676-9. PubMed ID: 6130922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penclomedine-induced DNA fragmentation and p53 accumulation correlate with reproductive cell death in colorectal carcinoma cells with altered p53 status.
    Rakovitch E; Mellado W; Hall EJ; Sawant SG; Geard CR; Newman RA; Pandita TK
    Oncol Rep; 1999; 6(1):161-5. PubMed ID: 9864421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.